Gene: ARHGAP29
Official Full Name: Rho GTPase activating protein 29provided by HGNC
Gene Summary: Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33242 | ARHGAP29 Knockout cell line (HeLa) | Human | ARHGAP29 | 1:3~1:6 | Negative | Online Inquiry |
KO33243 | ARHGAP29 Knockout cell line (HCT 116) | Human | ARHGAP29 | 1:2~1:4 | Negative | Online Inquiry |
KO33244 | ARHGAP29 Knockout cell line (HEK293) | Human | ARHGAP29 | 1:3~1:6 | Negative | Online Inquiry |
KO33245 | ARHGAP29 Knockout cell line (A549) | Human | ARHGAP29 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP29 Gene Knockout Cell Lines are specialized biological tools created to study the role of the ARHGAP29 gene, which encodes a protein involved in regulating Rho GTPase activities within cells, thereby influencing various cellular processes such as cell migration, cytoskeletal organization, and signal transduction. These knockout cell lines are generated using the CRISPR-Cas9 gene editing technology, which allows for precise deletions of the ARHGAP29 gene, resulting in the complete loss of ARHGAP29 function.
The primary mechanism through which these cell lines operate involves the lack of ARHGAP29 leading to altered regulation of Rho family GTPases, such as RhoA and Rac1. This alteration can result in profound effects on cellular behaviors, including enhanced cell motility, changes in actin dynamics, and impacts on cellular signaling pathways. Consequently, researchers can utilize these knockout models to dissect the
function of ARHGAP29 in numerous biological contexts, including development, cancer biology, and immune response.
From a scientific perspective, ARHGAP29 Gene Knockout Cell Lines are invaluable in elucidating the molecular mechanisms by which ARHGAP29 influences physiological and pathological processes. Their applications range from fundamental research in cell biology to translational studies aimed at developing novel therapeutic strategies for diseases linked to aberrant Rho GTPase signaling.
Compared to conventional methods of gene silencing, such as RNA interference, the ARHGAP29 knockout cell lines offer permanent and unequivocal gene disruption, providing researchers with more reliable results. Unlike transient transfection methods that may produce variable knockdown efficiency, these knockout lines enable consistent experimental outcomes and facilitate long-term studies of cellular phenotypes.
By investing in ARHGAP29 Gene Knockout Cell Lines, researchers and clinicians gain a powerful resource to explore significant biological questions and therapeutic avenues. Our commitment to scientific excellence ensures that you receive high-quality, rigorously validated cell lines that empower your research endeavors. Our expertise in molecular biology and cell line development positions us as a trusted partner in advancing your scientific inquiries and innovations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.